(Q34155702)

31 July 2017

title

Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications (English)

1 reference

31 July 2017

0 references

Jim S Wu

1

1 reference

31 July 2017

Catherine Buettner

2

1 reference

31 July 2017

Howard Smithline

3

1 reference

31 July 2017

Long H Ngo

4

1 reference

31 July 2017

Robert L Greenman

5

1 reference

31 July 2017

publication date

1 January 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

43

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

76-81

1 reference

Association between statin-associated myopathy and skeletal muscle damage

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Large-scale chemical dissection of mitochondrial function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Impact of adherence to statins on coronary artery disease in primary prevention

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Skeletal muscle energetics with PNMR: personal views and historic perspectives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Molecular clues into the pathogenesis of statin-mediated muscle toxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Statin-associated myopathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Statin-associated myopathy with normal creatine kinase levels

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Safety of HMG-CoA reductase inhibitors: focus on atorvastatin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Statin myopathies: pathophysiologic and clinical perspectives.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

HMG-CoA reductase inhibitors and myotoxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3332539

Adherence to statin therapy: why aren't we doing better?

5 July 2018

1 reference

Statin induced myopathy does not show up in MIBI scintigraphy

21 January 2018

1 reference

Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.

21 January 2018

1 reference

Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR.

21 January 2018

1 reference

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

21 January 2018

1 reference

Early changes in the skin microcirculation and muscle metabolism of the diabetic foot

21 January 2018

1 reference

High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy.

21 January 2018

1 reference

Metabolic recovery in professional road cyclists: a 31P-MRS study

21 January 2018

1 reference

Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study

21 January 2018

1 reference

12 December 2020

Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis

1 reference

12 December 2020

Statins--challenges and provocations

1 reference

12 December 2020

Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?

1 reference

12 December 2020

In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects

1 reference

12 December 2020

Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia

1 reference

12 December 2020

Elevated skeletal muscle phosphodiesters in adults using statin medications

1 reference

12 December 2020

Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure

1 reference

12 December 2020

Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin

1 reference

12 December 2020

Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin

1 reference

12 December 2020

Findings on (18)FDG-PET imaging in statin-induced rhabdomyolysis

1 reference

12 December 2020

Identifiers

DOI

10.1002/MUS.21847

1 reference

31 July 2017

1 reference

31 July 2017

1 reference